𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of vitamin K3 on the first-pass elimination of propranolol in the rat

✍ Scribed by Ryozo Ishida; Takashi Usui; Yoshiko Fukushima; Shoichi Fujita; Tokuji Suzuki


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
414 KB
Volume
74
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of propranolol on bone metabolis
✍ Dr. Barbara Minkowitz; Adele L. Boskey; Joseph M. Lane; Hubert S. Pearlman; Vinc πŸ“‚ Article πŸ“… 1991 πŸ› Elsevier Science 🌐 English βš– 716 KB

## Abstract Propranolol, a nonspecific β‐blocker, has many physiologic effects. Its effects on bone in vivo are unknown, although Ξ² receptor sites have been found on osteoblasts. In this study, the hypothesis tested was that low doses of propranolol could alter bone properties and enhance orthotopi

Pharmacokinetics and hepatic first-pass
✍ Inmaculada Soria; Dr. Cheryl L. Zimmerman πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 300 KB πŸ‘ 2 views

Studies were designed to allow an in vivo estimation of the hepatic extraction ratio and to test the hypothesis that the pharmacokinetic parameters of (-)-CBV are significantly different during anesthesia. (-)-CBV was administered as an IV bolus followed by IV infusion into either the portal (n = 3)

EXTRAHEPATIC FIRST-PASS METABOLISM OF NI
✍ JOHN S. GRUNDY; LISE A. ELIOT; ROBERT T. FOSTER πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 2 views

The peroral (po) bioavailability of nifedipine is reported to range from about 45 to 58% in the rat; this compares favourably to human beings. The metabolism of nifedipine is similar in rats and humans (oxidation of the dihydropyridine ring), with the liver believed to be solely responsible for the